SOX10 Neurocristopathy Spectrum

Genetic MONDO:0013202 Pathograph 10 Waardenburg Syndrome Neurocristopathy Sensorineural Hearing Loss

SOX10 neurocristopathy spectrum is a gene-axis disorder spanning auditory-pigmentary Waardenburg presentations, Waardenburg-Shah syndrome type 4C, and severe PCWH/PCW phenotypes. SOX10 encodes a neural crest and glial lineage transcription factor that regulates melanocyte, enteric nervous system, Schwann-cell, and oligodendrocyte development. The spectrum includes haploinsufficiency from deletions and NMD-sensitive truncating variants, plus NMD-escaping truncating variants that produce expressed mutant SOX10 proteins with dominant-negative or toxic altered-function effects, especially in PCWH.

Ask OpenScientist

Ask a research question about SOX10 Neurocristopathy Spectrum. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
7
Pathophys.
4
Phenotypes
10
Pathograph
1
Genes
3
Subtypes
1
Deep Research
👪

Inheritance

1
Autosomal dominant inheritance HP:0000006
SOX10 Waardenburg and PCWH presentations are typically heterozygous autosomal dominant conditions, frequently de novo, with variable expressivity across auditory-pigmentary, enteric, and glial phenotypes.
Autosomal dominant inheritance Penetrance: INCOMPLETE
◆

Subtypes

3
Waardenburg Syndrome Type 2E MONDO:0012698
A SOX10-related auditory-pigmentary form without Hirschsprung disease. Deletions and other SOX10 variants can present as WS2.
Show evidence (1 reference)
PMID:17999358 SUPPORT Human Clinical
"We also found SOX10 deletions in WS2 cases, making SOX10 a new gene of WS2."
Supports SOX10-related WS2 presentations within the broader spectrum.
Waardenburg Syndrome Type 4C MONDO:0013202
A Waardenburg-Shah form in which SOX10 variants cause auditory-pigmentary abnormalities together with Hirschsprung disease.
Show evidence (1 reference)
PMID:9462749 SUPPORT Human Clinical
"patients from four families with WS4 have mutations in SOX10"
Establishes SOX10 mutations in Waardenburg-Hirschsprung disease.
Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease MONDO:0012198
A severe SOX10 sub-spectrum usually associated with truncating variants that escape nonsense-mediated decay and produce an expressed mutant protein.
Show evidence (1 reference)
PMID:15004559 SUPPORT Human Clinical
"Our experiments show that triggering NMD and escaping NMD may cause distinct neurological phenotypes."
Supports PCWH as a mechanism-defined SOX10 sub-spectrum separated by NMD status.
⚙

Pathophysiology

7
SOX10 neural crest and glial lineage dysfunction
Pathogenic SOX10 variants disrupt a transcription factor required in neural crest derivatives and myelinating glia. This single upstream defect can affect melanocytes, enteric neurons, Schwann cells, and oligodendrocytes.
migratory neural crest cell link Schwann cell link oligodendrocyte link
SOX10 link
Downstream
SOX10 haploinsufficiency arm Deletions and NMD-sensitive truncating variants reduce functional SOX10 dosage.
NMD-escaping truncated SOX10 protein Some truncating variants escape NMD and produce a mutant protein linked to severe PCWH.
Show evidence (2 references)
PMID:9462749 SUPPORT Human Clinical
"Our findings further define the locus heterogeneity of Waardenburg-Hirschsprung syndromes, and point to an essential role of SOX10 in the development of two neural crest-derived human cell"
Identifies SOX10 as an essential neural crest developmental factor in Waardenburg-Hirschsprung disease.
PMID:34667088 SUPPORT Other
"heterozygous mutations have been reported in Waardenburg syndrome type 2 (Waardenburg syndrome type without Hirschsprung disease), PCWH or PCW"
Reviews the broader SOX10 phenotypic plurality across WS2, WS4, and PCWH.
SOX10 haploinsufficiency arm
Whole-gene or regulatory deletions and NMD-sensitive truncating alleles reduce SOX10 dosage. This mechanism supports WS2E and WS4C presentations and can overlap neurologically in some deletion cases.
SOX10 link
Downstream
Reduced SOX10-MITF and SOX10-RET regulatory programs SOX10 dosage loss reduces transcriptional activation of melanocyte and enteric regulatory targets.
Show evidence (2 references)
PMID:9462749 SUPPORT Human Clinical
"These mutations are likely to result in haploinsufficiency of the SOX10 product."
Supports SOX10 haploinsufficiency as a mechanism for Waardenburg-Hirschsprung disease.
PMID:17999358 SUPPORT Human Clinical
"We describe the first characterization of SOX10 deletions in patients presenting with WS4. We also found SOX10 deletions in WS2 cases, making SOX10 a new gene of WS2."
Extends the SOX10 deletion/haploinsufficiency mechanism across WS4 and WS2 presentations.
NMD-escaping truncated SOX10 protein
Truncating SOX10 variants in NMD-insensitive positions can escape nonsense-mediated decay, allowing production of a truncated protein with dominant-negative or toxic altered-function activity. This mechanism is strongly linked to the severe PCWH sub-spectrum.
SOX10 link
Downstream
Abnormal myelinating glial development Expressed mutant SOX10 can severely disrupt Schwann-cell and oligodendrocyte myelination programs.
Enteric nervous system developmental failure Severe SOX10 dysfunction impairs enteric neural crest development.
Show evidence (2 references)
PMID:15004559 SUPPORT Human Clinical
"the more severe disease phenotype, PCWH, is realized only when the mutant mRNAs escape the nonsense-mediated decay (NMD) pathway"
Directly supports the PCWH mechanism split by SOX10 NMD escape.
PMID:29681101 SUPPORT Human Clinical
"The p.Ser282GlnfsTer12 mutation presumably escapes from nonsense-mediated decay and may generate a dominant-negative effect."
Provides a PCWH case-level example of an NMD-escaping SOX10 frameshift variant.
Reduced SOX10-MITF and SOX10-RET regulatory programs
SOX10 regulates MITF in melanocyte lineage cells and interacts with PAX3 at MITF and RET regulatory elements, linking SOX10 variants to melanocyte and enteric nervous system developmental failure.
melanoblast link enteric neuron link
SOX10 link MITF link
melanocyte differentiation link ↓ DECREASED enteric nervous system development link ⚠ ABNORMAL
Downstream
Melanocyte lineage failure Reduced SOX10-MITF regulation impairs melanocyte differentiation and pigmentary/auditory development.
Enteric nervous system developmental failure Reduced SOX10-RET/EDNRB-axis function contributes to Hirschsprung disease.
Show evidence (2 references)
PMID:10938265 SUPPORT In Vitro
"we demonstrate that Sox10 is a strong activator of the MITF promoter"
Supports SOX10 regulation of MITF as a melanocyte lineage mechanism.
PMID:12668617 SUPPORT In Vitro
"The Pax3 and Sox10 transcription factors can directly regulate both MITF and c-RET."
Links SOX10 to MITF and RET regulatory programs relevant to melanocyte and enteric neural crest phenotypes.
Melanocyte lineage failure
SOX10 dysfunction impairs melanocyte lineage differentiation and survival, producing auditory-pigmentary Waardenburg features.
melanocyte link
melanocyte differentiation link ↓ DECREASED
Downstream
Stria vascularis melanocyte deficiency Cochlear melanocyte deficiency contributes to sensorineural hearing impairment.
Pigmentary developmental abnormality Cutaneous, hair, and iris melanocyte deficiency produces pigmentary findings.
Enteric nervous system developmental failure
SOX10 transcriptional dysfunction impairs enteric neural crest colonization, differentiation, and survival, causing Hirschsprung disease in WS4C/PCWH.
enteric neuron link
enteric nervous system development link ⚠ ABNORMAL
Show evidence (1 reference)
PMID:9462749 SUPPORT Human Clinical
"Hirschsprung's disease (HSCR; aganglionic megacolon)"
Establishes enteric aganglionosis as part of SOX10-associated Waardenburg-Hirschsprung disease.
Abnormal myelinating glial development
Severe SOX10 dysfunction in the PCWH sub-spectrum disrupts Schwann-cell and oligodendrocyte development, producing peripheral demyelinating neuropathy and central dysmyelinating leukodystrophy.
Schwann cell link oligodendrocyte link
myelination link ⚠ ABNORMAL
Show evidence (1 reference)
PMID:29681101 SUPPORT Human Clinical
"She also showed hypopigmentation of the irises, hair and skin, bilateral sensorineural deafness with hypoplastic inner year, severe demyelinating neuropathy with hypotonia, and diffuse brain hypomyelination."
Documents peripheral and central myelin involvement in a SOX10 PCWH case.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Referential integrity issues (2):
  • Target 'Stria vascularis melanocyte deficiency' (from 'Melanocyte lineage failure') not found in named elements
  • Target 'Pigmentary developmental abnormality' (from 'Melanocyte lineage failure') not found in named elements
Pathograph: causal mechanism network for SOX10 Neurocristopathy Spectrum Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

4
Ear 1
Sensorineural hearing impairment VERY_FREQUENT Sensorineural hearing impairment (HP:0000407)
Show evidence (1 reference)
PMID:9462749 SUPPORT Human Clinical
"Waardenburg syndrome (WS; deafness with pigmentary abnormalities) and Hirschsprung's disease (HSCR; aganglionic megacolon) are congenital disorders"
Identifies deafness as part of the SOX10-associated Waardenburg disease context.
Nervous System 1
Peripheral demyelinating neuropathy FREQUENT Peripheral neuropathy (HP:0009830)
Show evidence (1 reference)
PMID:29681101 SUPPORT Human Clinical
"In this report, we present the case of a female infant with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease (PCWH) associated with a novel frameshift mutation (c.842dupT) in exon 5, the last exon of SOX10."
Documents peripheral demyelinating neuropathy as part of a SOX10-associated PCWH case.
Other 2
Pigmentary abnormality VERY_FREQUENT
Show evidence (1 reference)
PMID:9462749 SUPPORT Human Clinical
"Waardenburg syndrome (WS; deafness with pigmentary abnormalities) and Hirschsprung's disease (HSCR; aganglionic megacolon) are congenital disorders"
Identifies pigmentary abnormalities as a defining Waardenburg feature in the SOX10 discovery context.
Aganglionic megacolon FREQUENT Aganglionic megacolon (HP:0002251)
Show evidence (1 reference)
PMID:9462749 SUPPORT Human Clinical
"Hirschsprung's disease (HSCR; aganglionic megacolon)"
Confirms aganglionic megacolon as the enteric component of Waardenburg-Hirschsprung disease.
🧬

Genetic Associations

1
SOX10 (Causative)
Show evidence (1 reference)
PMID:34667088 SUPPORT Other
"Since then, heterozygous mutations have been reported in Waardenburg syndrome type 2 (Waardenburg syndrome type without Hirschsprung disease), PCWH or PCW"
Reviews the SOX10 genotype-phenotype spectrum.
{ }

Source YAML

click to show 
name: SOX10 Neurocristopathy Spectrum
creation_date: '2026-05-28T00:00:00Z'
description: >-
  SOX10 neurocristopathy spectrum is a gene-axis disorder spanning
  auditory-pigmentary Waardenburg presentations, Waardenburg-Shah syndrome type
  4C, and severe PCWH/PCW phenotypes. SOX10 encodes a neural crest and glial
  lineage transcription factor that regulates melanocyte, enteric nervous
  system, Schwann-cell, and oligodendrocyte development. The spectrum includes
  haploinsufficiency from deletions and NMD-sensitive truncating variants, plus
  NMD-escaping truncating variants that produce expressed mutant SOX10 proteins
  with dominant-negative or toxic altered-function effects, especially in PCWH.
category: Genetic
parents:
- Waardenburg Syndrome
- Neurocristopathy
- Sensorineural Hearing Loss
disease_term:
  preferred_term: Waardenburg syndrome type 4C
  term:
    id: MONDO:0013202
    label: Waardenburg syndrome type 4C
tracked_issues:
- url: https://github.com/monarch-initiative/dismech/issues/3309
  title: Curate Waardenburg syndrome as gene-axis mechanism spectra
  tracked_issue_role: curation_followup
  tracked_issue_status: OPEN
  notes: >-
    Issue 3309 requested a SOX10 spectrum entry and explicit PCWH
    NMD-escape/truncation modeling.
external_assertions:
- name: ClinGen SOX10 Waardenburg syndrome type 4C validity assertion
  source: ClinGen
  assertion_type: gene_disease_validity
  external_id: CGGV:assertion_00a5b707-a265-4af0-a7e1-f15734ea42b9-2018-06-19T160000.000Z
  url: https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_00a5b707-a265-4af0-a7e1-f15734ea42b9-2018-06-19T160000.000Z
  description: >-
    ClinGen Hearing Loss Gene Curation Expert Panel assertion classifying SOX10
    and autosomal dominant Waardenburg syndrome type 4C as Definitive.
  evidence:
  - reference: CGGV:assertion_00a5b707-a265-4af0-a7e1-f15734ea42b9-2018-06-19T160000.000Z
    reference_title: SOX10 / Waardenburg syndrome type 4C (Definitive)
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In summary, SOX10 is definitively associated with autosomal dominant Waardenburg syndrome.
    explanation: >-
      ClinGen provides the structured gene-disease validity assertion for the
      SOX10 Waardenburg spectrum anchor.
has_subtypes:
- name: Waardenburg Syndrome Type 2E
  display_name: Waardenburg Syndrome Type 2E
  subtype_term:
    preferred_term: Waardenburg syndrome type 2E
    term:
      id: MONDO:0012698
      label: Waardenburg syndrome type 2E
  description: >-
    A SOX10-related auditory-pigmentary form without Hirschsprung disease.
    Deletions and other SOX10 variants can present as WS2.
  evidence:
  - reference: PMID:17999358
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We also found SOX10 deletions in WS2 cases, making SOX10 a new gene of WS2.
    explanation: >-
      Supports SOX10-related WS2 presentations within the broader spectrum.
- name: Waardenburg Syndrome Type 4C
  display_name: Waardenburg Syndrome Type 4C
  subtype_term:
    preferred_term: Waardenburg syndrome type 4C
    term:
      id: MONDO:0013202
      label: Waardenburg syndrome type 4C
  description: >-
    A Waardenburg-Shah form in which SOX10 variants cause auditory-pigmentary
    abnormalities together with Hirschsprung disease.
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients from four families with WS4 have mutations in SOX10
    explanation: >-
      Establishes SOX10 mutations in Waardenburg-Hirschsprung disease.
- name: PCWH Syndrome
  display_name: Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease
  subtype_term:
    preferred_term: PCWH syndrome
    term:
      id: MONDO:0012198
      label: PCWH syndrome
  description: >-
    A severe SOX10 sub-spectrum usually associated with truncating variants that
    escape nonsense-mediated decay and produce an expressed mutant protein.
  evidence:
  - reference: PMID:15004559
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our experiments show that triggering NMD and escaping NMD may cause distinct neurological phenotypes.
    explanation: >-
      Supports PCWH as a mechanism-defined SOX10 sub-spectrum separated by NMD
      status.
inheritance:
- name: Autosomal dominant inheritance
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  penetrance: INCOMPLETE
  description: >-
    SOX10 Waardenburg and PCWH presentations are typically heterozygous
    autosomal dominant conditions, frequently de novo, with variable
    expressivity across auditory-pigmentary, enteric, and glial phenotypes.
phenotypes:
- category: Audiological
  name: Sensorineural hearing impairment
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  description: >-
    Hearing impairment reflects the Waardenburg-spectrum melanocyte and inner
    ear component of SOX10 dysfunction.
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Waardenburg syndrome (WS; deafness with pigmentary abnormalities) and Hirschsprung's disease (HSCR; aganglionic megacolon) are congenital disorders
    explanation: >-
      Identifies deafness as part of the SOX10-associated Waardenburg disease
      context.
- category: Dermatologic
  name: Pigmentary abnormality
  frequency: VERY_FREQUENT
  description: >-
    Hypopigmentation, white forelock, and iris/hair/skin pigmentary anomalies
    result from SOX10-dependent melanocyte developmental failure.
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Waardenburg syndrome (WS; deafness with pigmentary abnormalities) and Hirschsprung's disease (HSCR; aganglionic megacolon) are congenital disorders
    explanation: >-
      Identifies pigmentary abnormalities as a defining Waardenburg feature in
      the SOX10 discovery context.
- category: Gastrointestinal
  name: Aganglionic megacolon
  subtype: Waardenburg Syndrome Type 4C
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Aganglionic megacolon
    term:
      id: HP:0002251
      label: Aganglionic megacolon
  description: >-
    Hirschsprung disease results from impaired enteric neural crest development
    in the SOX10 WS4C/PCWH portion of the spectrum.
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hirschsprung's disease (HSCR; aganglionic megacolon)
    explanation: >-
      Confirms aganglionic megacolon as the enteric component of
      Waardenburg-Hirschsprung disease.
- category: Neurologic
  name: Peripheral demyelinating neuropathy
  subtype: PCWH Syndrome
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Peripheral neuropathy
    term:
      id: HP:0009830
      label: Peripheral neuropathy
  description: >-
    Peripheral neuropathy occurs in the severe PCWH portion of the SOX10
    spectrum due to Schwann-cell/myelination dysfunction.
  evidence:
  - reference: PMID:29681101
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this report, we present the case of a female infant with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease (PCWH) associated with a novel frameshift mutation (c.842dupT) in exon 5, the last exon of SOX10.
    explanation: >-
      Documents peripheral demyelinating neuropathy as part of a
      SOX10-associated PCWH case.
pathophysiology:
- name: SOX10 neural crest and glial lineage dysfunction
  description: >-
    Pathogenic SOX10 variants disrupt a transcription factor required in neural
    crest derivatives and myelinating glia. This single upstream defect can
    affect melanocytes, enteric neurons, Schwann cells, and oligodendrocytes.
  genes:
  - preferred_term: SOX10
    term:
      id: hgnc:11190
      label: SOX10
  cell_types:
  - preferred_term: migratory neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  - preferred_term: Schwann cell
    term:
      id: CL:0002573
      label: Schwann cell
  - preferred_term: oligodendrocyte
    term:
      id: CL:0000128
      label: oligodendrocyte
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings further define the locus heterogeneity of Waardenburg-Hirschsprung syndromes, and point to an essential role of SOX10 in the development of two neural crest-derived human cell
    explanation: >-
      Identifies SOX10 as an essential neural crest developmental factor in
      Waardenburg-Hirschsprung disease.
  - reference: PMID:34667088
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      heterozygous mutations have been reported in Waardenburg syndrome type 2 (Waardenburg syndrome type without Hirschsprung disease), PCWH or PCW
    explanation: >-
      Reviews the broader SOX10 phenotypic plurality across WS2, WS4, and PCWH.
  downstream:
  - target: SOX10 haploinsufficiency arm
    description: >-
      Deletions and NMD-sensitive truncating variants reduce functional SOX10
      dosage.
  - target: NMD-escaping truncated SOX10 protein
    description: >-
      Some truncating variants escape NMD and produce a mutant protein linked to
      severe PCWH.
- name: SOX10 haploinsufficiency arm
  description: >-
    Whole-gene or regulatory deletions and NMD-sensitive truncating alleles
    reduce SOX10 dosage. This mechanism supports WS2E and WS4C presentations
    and can overlap neurologically in some deletion cases.
  genes:
  - preferred_term: SOX10
    term:
      id: hgnc:11190
      label: SOX10
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These mutations are likely to result in haploinsufficiency of the SOX10 product.
    explanation: >-
      Supports SOX10 haploinsufficiency as a mechanism for
      Waardenburg-Hirschsprung disease.
  - reference: PMID:17999358
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe the first characterization of SOX10 deletions in patients presenting with WS4. We also found SOX10 deletions in WS2 cases, making SOX10 a new gene of WS2.
    explanation: >-
      Extends the SOX10 deletion/haploinsufficiency mechanism across WS4 and
      WS2 presentations.
  downstream:
  - target: Reduced SOX10-MITF and SOX10-RET regulatory programs
    description: >-
      SOX10 dosage loss reduces transcriptional activation of melanocyte and
      enteric regulatory targets.
- name: NMD-escaping truncated SOX10 protein
  description: >-
    Truncating SOX10 variants in NMD-insensitive positions can escape
    nonsense-mediated decay, allowing production of a truncated protein with
    dominant-negative or toxic altered-function activity. This mechanism is
    strongly linked to the severe PCWH sub-spectrum.
  genes:
  - preferred_term: SOX10
    term:
      id: hgnc:11190
      label: SOX10
  evidence:
  - reference: PMID:15004559
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the more severe disease phenotype, PCWH, is realized only when the mutant mRNAs escape the nonsense-mediated decay (NMD) pathway
    explanation: >-
      Directly supports the PCWH mechanism split by SOX10 NMD escape.
  - reference: PMID:29681101
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The p.Ser282GlnfsTer12 mutation presumably escapes from nonsense-mediated decay and may generate a dominant-negative effect.
    explanation: >-
      Provides a PCWH case-level example of an NMD-escaping SOX10 frameshift
      variant.
  downstream:
  - target: Abnormal myelinating glial development
    description: >-
      Expressed mutant SOX10 can severely disrupt Schwann-cell and
      oligodendrocyte myelination programs.
  - target: Enteric nervous system developmental failure
    description: >-
      Severe SOX10 dysfunction impairs enteric neural crest development.
- name: Reduced SOX10-MITF and SOX10-RET regulatory programs
  conforms_to: "neural_crest_melanocyte_deficiency#Neural Crest Melanocyte Program Disruption"
  description: >-
    SOX10 regulates MITF in melanocyte lineage cells and interacts with PAX3 at
    MITF and RET regulatory elements, linking SOX10 variants to melanocyte and
    enteric nervous system developmental failure.
  genes:
  - preferred_term: SOX10
    term:
      id: hgnc:11190
      label: SOX10
  - preferred_term: MITF
    term:
      id: hgnc:7105
      label: MITF
  cell_types:
  - preferred_term: melanoblast
    term:
      id: CL:0000541
      label: melanoblast
  - preferred_term: enteric neuron
    term:
      id: CL:0007011
      label: enteric neuron
  biological_processes:
  - preferred_term: melanocyte differentiation
    term:
      id: GO:0030318
      label: melanocyte differentiation
    modifier: DECREASED
  - preferred_term: enteric nervous system development
    term:
      id: GO:0048484
      label: enteric nervous system development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:10938265
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      we demonstrate that Sox10 is a strong activator of the MITF promoter
    explanation: >-
      Supports SOX10 regulation of MITF as a melanocyte lineage mechanism.
  - reference: PMID:12668617
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The Pax3 and Sox10 transcription factors can directly regulate both MITF and c-RET.
    explanation: >-
      Links SOX10 to MITF and RET regulatory programs relevant to melanocyte and
      enteric neural crest phenotypes.
  downstream:
  - target: Melanocyte lineage failure
    description: >-
      Reduced SOX10-MITF regulation impairs melanocyte differentiation and
      pigmentary/auditory development.
  - target: Enteric nervous system developmental failure
    description: >-
      Reduced SOX10-RET/EDNRB-axis function contributes to Hirschsprung disease.
- name: Melanocyte lineage failure
  conforms_to: "neural_crest_melanocyte_deficiency#Melanoblast Migration and Survival Defect"
  description: >-
    SOX10 dysfunction impairs melanocyte lineage differentiation and survival,
    producing auditory-pigmentary Waardenburg features.
  cell_types:
  - preferred_term: melanocyte
    term:
      id: CL:0000148
      label: melanocyte
  biological_processes:
  - preferred_term: melanocyte differentiation
    term:
      id: GO:0030318
      label: melanocyte differentiation
    modifier: DECREASED
  downstream:
  - target: Stria vascularis melanocyte deficiency
    description: >-
      Cochlear melanocyte deficiency contributes to sensorineural hearing
      impairment.
  - target: Pigmentary developmental abnormality
    description: >-
      Cutaneous, hair, and iris melanocyte deficiency produces pigmentary
      findings.
- name: Enteric nervous system developmental failure
  description: >-
    SOX10 transcriptional dysfunction impairs enteric neural crest colonization,
    differentiation, and survival, causing Hirschsprung disease in WS4C/PCWH.
  cell_types:
  - preferred_term: enteric neuron
    term:
      id: CL:0007011
      label: enteric neuron
  biological_processes:
  - preferred_term: enteric nervous system development
    term:
      id: GO:0048484
      label: enteric nervous system development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:9462749
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hirschsprung's disease (HSCR; aganglionic megacolon)
    explanation: >-
      Establishes enteric aganglionosis as part of SOX10-associated
      Waardenburg-Hirschsprung disease.
- name: Abnormal myelinating glial development
  description: >-
    Severe SOX10 dysfunction in the PCWH sub-spectrum disrupts Schwann-cell and
    oligodendrocyte development, producing peripheral demyelinating neuropathy
    and central dysmyelinating leukodystrophy.
  cell_types:
  - preferred_term: Schwann cell
    term:
      id: CL:0002573
      label: Schwann cell
  - preferred_term: oligodendrocyte
    term:
      id: CL:0000128
      label: oligodendrocyte
  biological_processes:
  - preferred_term: myelination
    term:
      id: GO:0042552
      label: myelination
    modifier: ABNORMAL
  evidence:
  - reference: PMID:29681101
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She also showed hypopigmentation of the irises, hair and skin, bilateral sensorineural deafness with hypoplastic inner year, severe demyelinating neuropathy with hypotonia, and diffuse brain hypomyelination.
    explanation: >-
      Documents peripheral and central myelin involvement in a SOX10 PCWH case.
genetic:
- name: SOX10
  gene_term:
    preferred_term: SOX10
    term:
      id: hgnc:11190
      label: SOX10
  association: Causative
  features: >-
    Heterozygous SOX10 deletions, missense variants, and truncating variants
    cause a spectrum ranging from WS2E to WS4C and PCWH. Variant position and
    NMD sensitivity help determine whether the mechanism behaves as
    haploinsufficiency or expressed mutant-protein toxicity.
  evidence:
  - reference: PMID:34667088
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Since then, heterozygous mutations have been reported in Waardenburg syndrome type 2 (Waardenburg syndrome type without Hirschsprung disease), PCWH or PCW
    explanation: >-
      Reviews the SOX10 genotype-phenotype spectrum.
notes: >-
  This entry cross-links conceptually to PCWH_syndrome.yaml, which remains a
  separate MONDO-anchored disorder entry. PCWH is represented here as a severe
  SOX10 sub-spectrum and in PCWH_syndrome.yaml as the specific clinical entity.
📚

References & Deep Research

Deep Research

1
Falcon ▸
Disease Characteristics Research Template
Edison Scientific Literature 2026-05-28T12:02:19.043005

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

  • Disease Name: SOX10 Neurocristopathy Spectrum
  • MONDO ID: (if available)
  • Category: Genetic

Research Objectives

Please provide a comprehensive research report on SOX10 Neurocristopathy Spectrum covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.

1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

  • What is the disease? Provide a concise overview.
  • What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
  • What are the common synonyms and alternative names?
  • Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

  • Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
  • Risk Factors:

    Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases

  • Genetic risk factors (causal variants, susceptibility loci, modifier genes)
  • Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
  • Protective Factors:

    Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases

  • Genetic protective factors (protective variants, modifier alleles)
  • Environmental protective factors (diet, lifestyle, exposures that reduce risk)
  • Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

    Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

  • Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

    Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene

  • Pathogenic Variants:
  • Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
  • Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
  • Variant type/class (missense, frameshift, nonsense, splice-site, structural)
  • Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
  • Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
  • Functional consequences (loss of function, gain of function, dominant negative)
  • Modifier Genes: Genes that modify disease severity or expression
  • Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

    Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

  • Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

    Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases

  • Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

    Search first: CDC databases, WHO, PubMed, NHANES

  • Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

    Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

  • Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

    Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc

  • Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

    Search first: Gene Ontology (GO), Reactome, KEGG, PubMed

  • Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

    Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold

  • Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

    Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA

  • Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

    Search first: ImmPort, Immunome Database, IEDB, Gene Ontology

  • Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

    Search first: PubMed, Gene Ontology, Reactome

  • Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

    Search first: BRENDA, UniProt, KEGG, OMIM, PubMed

  • Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Molecular Profiling (if available):
  • Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
  • Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
  • Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
  • Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
  • Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
  • Advanced Technologies (if applicable):
  • Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
  • Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
  • Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
  • Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

  • Organ Level:
  • Primary organs directly affected
  • Secondary organ involvement (complications, secondary effects)
  • Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

    Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT

  • Tissue and Cell Level:
  • Specific tissue types affected (epithelial, connective, muscle, nervous)
  • Specific cell populations targeted (with Cell Ontology terms)

    Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB

  • Subcellular Level:
  • Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

    Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas

  • Localization:
  • Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
  • Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

  • Onset:
  • Typical age of onset (congenital, pediatric, adult, geriatric)
  • Onset pattern (acute, subacute, chronic, insidious)

    Search first: OMIM, Orphanet, HPO, PubMed

  • Progression:
  • Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
  • Progression rate (rapid, slow, variable)
  • Disease course pattern (episodic, relapsing-remitting, progressive, stable)
  • Disease duration (self-limited, chronic lifelong)

    Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM

  • Patterns:
  • Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
  • Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

  • Epidemiology:
  • Prevalence (cases per 100,000 at given time)
  • Incidence (new cases per 100,000 per year)

    Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries

  • For Genetic Etiology:
  • Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
  • Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
  • Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
  • Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
  • Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
  • Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
  • Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
  • Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
  • Population Demographics:
  • Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
  • Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
  • Geographic distribution of specific variants
  • Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
  • Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

  • Clinical Tests:
  • Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
  • Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
  • Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
  • Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
  • Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
  • Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
  • Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
  • Genetic Testing:

    Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen

  • Overview of recommended genetic testing approach
  • Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
  • Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
  • Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
  • Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
  • Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
  • Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
  • FISH > Search first: ClinVar, cytogenetics databases, PubMed
  • Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
  • Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
  • Omics-Based Diagnostics (if applicable):
  • RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
  • Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
  • Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
  • Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
  • Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
  • Clinical Criteria:
  • Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
  • Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
  • Screening:
  • Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

  • Survival and Mortality:
  • Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
  • Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
  • Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
  • Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
  • Morbidity and Function:
  • Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
  • Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
  • Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
  • Disease Course:
  • Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
  • Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
  • Prediction:
  • Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
  • Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

  • Pharmacotherapy:
  • Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
  • Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
  • Advanced Therapeutics:
  • Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
  • Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
  • RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
  • Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
  • Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
  • Surgical and Interventional:
  • Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
  • Supportive and Rehabilitative:
  • Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
  • Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
  • Experimental:
  • Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
  • Treatment Outcomes:
  • Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
  • Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
  • Treatment Strategy:
  • Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
  • Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
  • Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest MAXO (Medical Action Ontology) terms where applicable.

13. Prevention

  • Prevention Levels:
  • Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
  • Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
  • Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
  • Immunization: Vaccine strategies (if applicable)

    Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database

  • Screening and Early Detection:
  • Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
  • Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
  • Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
  • Behavioral Interventions: Lifestyle modifications to reduce risk

    Search first: CDC, WHO, behavioral intervention databases, Cochrane Library

  • Counseling: Genetic counseling (risk assessment, family planning guidance)

    Search first: NSGC resources, ACMG guidelines, GeneReviews

  • Public Health:
  • Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
  • Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
  • Prophylaxis: Preventive medications or procedures

    Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

  • Taxonomy: Species affected (with NCBI Taxon identifiers)

    Search first: NCBI Taxonomy

  • Breed: Specific breeds affected (with VBO identifiers if applicable)

    Search first: VBO (Vertebrate Breed Ontology)

  • Gene: Orthologous genes in other species (with NCBI Gene IDs)

    Search first: NCBI Gene

  • Natural Disease:
  • Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
  • Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
  • Comparative Biology:
  • Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
  • Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
  • Transmission (if applicable):
  • Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
  • Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

  • Model Types:
  • Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
  • Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
  • Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
  • Genetic Models:
  • Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
  • Model Characteristics:
  • Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
  • Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
  • Applications:
  • Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
  • Resources:
  • Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

  • Cite primary literature (PMID preferred) for all mechanistic and clinical claims
  • Prioritize recent reviews and landmark papers
  • Include direct quotes from abstracts where possible to support key statements
  • Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, MAXO, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (MAXO terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Warning: no contexts were retrieved, so this answer is not grounded in evidence but is instead a direct response from the agent model.

Unable to submit a cited report because no citable contexts were retrieved in this session (Paper Count=0), so the system has no context IDs to support any claims or citations.

Artifacts